Toxicological Sciences 56, 181-188 (2000)
Copyright © 2000 by the Society of Toxicology
Effects of Di-isononyl Phthalate, Di-2-ethylhexyl Phthalate, and Clofibrate in Cynomolgus Monkeys




,2
* Exxon Biomedical Sciences, Inc., East Millstone, New Jersey 08875;
Division of Toxicology, Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana 46202;
T.P.S., Inc., Mount Vernon, Indiana 47620; and
§ Research Pathology Services, Inc., New Britain, Pennsylvania 18901
The effects of the peroxisome proliferators di-isononyl phthalate (DINP) and di-2-ethylhexyl phthalate (DEHP) were evaluated in young adult male cynomolgus monkeys after 14 days of treatment, with emphasis on detecting hepatic and other effects seen in rats and mice after treatment with high doses of phthalates. Groups of 4 monkeys received DINP (500 mg/kg/day), DEHP (500 mg/kg/day), or vehicle (0.5% methyl cellulose, 10 ml/kg) by intragastric intubation for 14 consecutive days. Clofibrate (250 mg/kg/day), a hypolipidemic drug used for cholesterol reduction in human patients was used as a reference substance. None of the test substances had any effect on body weight or liver weights. Histopathological examination of tissues from these animals revealed no distinctive treatment-related effects in the liver, kidney, or testes. There were also no changes in any of the hepatic markers for peroxisomal proliferation, including peroxisomal beta-oxidation (PBOX) or replicative DNA synthesis. Additionally, in situ dye transfer studies using fresh liver slices revealed that DINP, DEHP, and clofibrate had no effect on gap junctional intercellular communication (GJIC). None of the test substances produced any toxicologically important changes in urinalysis, hematology, or clinical chemistry; however, clofibrate produced some emesis, small increases in serum triglyceride, decreased calcium, and decreased weights of testes/epididymides and thyroid/parathyroid. The toxicological significance of these small changes is questionable. The absence of observable hepatic effects in monkeys at doses that produce hepatic effects in rodents suggests that DINP, DEHP, and clofibrate would also not elicit in primates other effects such as liver cancer. These data, along with results from in vitro hepatocyte studies, indicate that rodents are not good animal models for predicting the hepatic effects of phthalates in primates, including humans.
Key Words: tumor promotion; nongenotoxic carcinogens; phthalate esters; gap junctions; intercellular communication; hepatocytes; peroxisomes.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. E. Talsness, A. J. M. Andrade, S. N. Kuriyama, J. A. Taylor, and F. S. vom Saal Components of plastic: experimental studies in animals and relevance for human health Phil Trans R Soc B, July 27, 2009; 364(1526): 2079 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ritter and T. E. Arbuckle Can Exposure Characterization Explain Concurrence or Discordance between Toxicology and Epidemiology? Toxicol. Sci., June 1, 2007; 97(2): 241 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Annual Review of Cosmetic Ingredient Safety Assessments--2002/2003 International Journal of Toxicology, January 1, 2005; 24(1_suppl): 1 - 2. [Full Text] [PDF] |
||||
![]() |
M. T. Bility, J. T. Thompson, R. H. McKee, R. M. David, J. H. Butala, J. P. Vanden Heuvel, and J. M. Peters Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters Toxicol. Sci., November 1, 2004; 82(1): 170 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Cattley Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis Toxicol Pathol, February 1, 2004; 32(2_suppl): 6 - 11. [Abstract] [PDF] |
||||
![]() |
H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Warner, M. J. Fernstrom, and R. J. Ruch Inhibition of Mouse Hepatocyte Gap Junctional Intercellular Communication by Phenobarbital Correlates with Strain-Specific Hepatocarcinogenesis Toxicol. Sci., February 1, 2003; 71(2): 190 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Butenhoff, G. Costa, C. Elcombe, D. Farrar, K. Hansen, H. Iwai, R. Jung, G. Kennedy Jr., P. Lieder, G. Olsen, et al. Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months Toxicol. Sci., September 1, 2002; 69(1): 244 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Seacat, P. J. Thomford, K. J. Hansen, G. W. Olsen, M. T. Case, and J. L. Butenhoff Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys Toxicol. Sci., July 1, 2002; 68(1): 249 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Isenberg, L. M. Kamendulis, D. C. Ackley, J. H. Smith, G. Pugh Jr., A. W. Lington, R. H. McKee, and J. E. Klaunig Reversibility and Persistence of Di-2-ethylhexyl Phthalate (DEHP)- and Phenobarbital-Induced Hepatocellular Changes in Rodents Toxicol. Sci., December 1, 2001; 64(2): 192 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Miller, L. A. Scappino, S. M. Long, and J. C. Corton Role of Thyroid Hormones in Hepatic Effects of Peroxisome Proliferators Toxicol Pathol, January 1, 2001; 29(1): 149 - 155. [Abstract] [PDF] |
||||




